Latest Breaking News On - Sabine ehrt - Page 1 : comparemela.com

Grants will fund tuberculosis drug development

Weill Cornell Medicine researchers and the TB Drug Accelerator have received two grants totaling $6.8 million from the Bill & Melinda Gates Foundation to study tuberculosis (TB) drug development. This effort will expedite finding new drug targets

Dirk schnappingerSabine ehrtMichael glickmanCarlf nathanSloan kettering institutePathogen biology at rockefeller universityWorld health organizationMelinda gates foundationLaboratory of hostWeill cornell medicineWorld healthJeremy rockHost pathogen biologyCornell medicine

Grants will fund tuberculosis drug development

Weill Cornell Medicine researchers and the TB Drug Accelerator have received two grants totaling $6.8 million from the Bill & Melinda Gates Foundation to study tuberculosis drug development.

Dirk schnappingerCarlf nathanMichael glickmanSabine ehrtPathogen biology at rockefeller universityWorld health organizationLaboratory of hostSloan kettering instituteMelinda gates foundationWeill cornell medicineWorld healthJeremy rockHost pathogen biologyCornell medicine

Researchers receive two grants to study tuberculosis drug development

Weill Cornell Medicine researchers and the TB Drug Accelerator have received two grants totaling $6.8 million from the Bill & Melinda Gates Foundation to study tuberculosis (TB) drug development.

Michael glickmanSabine ehrtCarlf nathanDirk schnappingerLaboratory of hostWorld health organizationPathogen biology at rockefeller universityMelinda gates foundationSloan kettering instituteCornell medicineWeill cornell medicineWorld healthJeremy rockHost pathogen biologyChest painInfectious diseases

$5 million NIH Center Grant Will Support Next Generation TB Research

$5 million NIH Center Grant Will Support Next Generation TB Research
cornell.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cornell.edu Daily Mail and Mail on Sunday newspapers.

Carl nathanMike glickmanSabine ehrtJean papeDaniel fitzgeraldJean laurent casanovaRockefeller universityGlobal healthNational institutes of healthNational institutes of allergyInstitutional tb research advancement centerMemorial sloan kettering cancer centerWeill cornell medicineNational institutesInfectious diseasesNew york tri institutional

Cornell University: Protein contributes to drug tolerance in tuberculosis

Weill Cornell Medicine researchers have identified a protein in Mycobacterium tuberculosis (Mtb) that contributes to drug tolerance, a phenomenon that allows bacteria to survive treatment with drugs that would normally kill them.The study, published

Kaj kreutzfeldtSabine ehrtDirk schnappingerNature communicationsWorld health organizationWeill cornell medicineWeill cornell